Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL is a synthetic organic compound classified as a dinitrophenol derivative. While specific drug development details for this exact compound are not readily available in public databases, its chemical structure suggests it likely functions as an uncoupler of oxidative phosphorylation, a mechanism shared by other dinitrophenols like 2,4-Dinitrophenol. This mechanism involves disrupting the proton gradient across the mitochondrial inner membrane, thereby inhibiting ATP synthesis and leading to energy dissipation as heat. PubChem classifies this compound as a pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL.